Based on the analysis of Intelligent Bio's profitability, liquidity, and operating efficiency, Intelligent Bio Solutions is not in a good financial situation at this time. It has a very high probability of going through financial hardship in August. At this time, Intelligent Bio's Net Invested Capital is comparatively stable compared to the past year. Key indicators impacting Intelligent Bio's financial strength include:
The financial analysis of Intelligent Bio is a critical element in measuring its lifeblood. Investors should not minimize Intelligent Bio's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Understanding current and past Intelligent Bio Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Intelligent Bio's financial statements are interrelated, with each one affecting the others. For example, an increase in Intelligent Bio's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Intelligent Bio's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Intelligent Bio Solutions. Check Intelligent Bio's Beneish M Score to see the likelihood of Intelligent Bio's management manipulating its earnings.
Intelligent Bio Stock Summary
Intelligent Bio competes with Dennys Corp, JBG SMITH, Lincoln Electric, Bt Brands, and Westrock Coffee. GBS Inc. operates as a biosensor diagnostic technology company in the Asia-Pacific and North America. GBS Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd. Intelligent Bio operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 12 people.
The reason investors look at the income statement is to determine what Intelligent Bio's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
Comparative valuation techniques use various fundamental indicators to help in determining Intelligent Bio's current stock value. Our valuation model uses many indicators to compare Intelligent Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Intelligent Bio competition to find correlations between indicators driving Intelligent Bio's intrinsic value. More Info.
Intelligent Bio Solutions is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . At this time, Intelligent Bio's Return On Equity is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Intelligent Bio by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Intelligent Bio Solutions Systematic Risk
Intelligent Bio's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Intelligent Bio volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Beta measures systematic risk based on how returns on Intelligent Bio Solutions correlated with the market. If Beta is less than 0 Intelligent Bio generally moves in the opposite direction as compared to the market. If Intelligent Bio Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Intelligent Bio Solutions is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Intelligent Bio is generally in the same direction as the market. If Beta > 1 Intelligent Bio moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Intelligent Bio Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Intelligent Bio's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Intelligent Bio growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of Intelligent Bio help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Intelligent Bio Solutions. We use our internally-developed statistical techniques to arrive at the intrinsic value of Intelligent Bio Solutions based on widely used predictive technical indicators. In general, we focus on analyzing Intelligent Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Intelligent Bio's daily price indicators and compare them against related drivers.
When running Intelligent Bio's price analysis, check to measure Intelligent Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelligent Bio is operating at the current time. Most of Intelligent Bio's value examination focuses on studying past and present price action to predict the probability of Intelligent Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelligent Bio's price. Additionally, you may evaluate how the addition of Intelligent Bio to your portfolios can decrease your overall portfolio volatility.